2019
研究業績
Papers (English)
Original papers
1. Adachi Y, Yoshikawa H, Yokoyama S, Iwasa K. Characteristics of University Students Supported by Counseling Services: Analysis of psychological tests and pulse rate variability. bioRxiv (In Press)
2. Buxbaum JN, Brannagan III TH, Cisneros-Barroso E, Buades J, Conceição I, Kyriakides T, Obici L, Merlini G, Planté-Bordeneuve V, Rousseau A, Sekijima Y, Waddington M, Yamada M. Transthyretin deposition in the eye in the era of effective therapy for hereditary amyloid polyneuropathy. Amyloid 26:10-14, 2019
3. Caunca MR, Gardener H, Simonetto M, Cheung YK, Alperin N, Yoshita M, DeCarli C, Elkind MSV, Sacco RL, Wright CB, Rundek T. Measures of obesity are associated with MRI markers of brain aging: The Northern Manhattan Study. Neurology 93:e791-e803, 2019
4. Hamaguchi T, Komatsu J, Sakai K, Noguchi-Shinohara M, Aoki S, Ikeuchi T, Yamada M. Cerebral hemorrhagic stroke associated with cerebral amyloid angiopathy in young adults about 3 decades after neurosurgeries in their infancy. J Neurol Sci 399: 3-5, 2019
5. Hamaguchi T, Sakai K, Kobayashi A, Kitamoto T, Ae R, Nakamura Y, Sanjo N, Arai K, Koide M, Katada F, Harada M, Murai H, Murayama S, Tsukamoto T, Mizusawa H, Yamada M. Characterization of “sporadic CJD” with history of neurosurgery to identify potentially iatrogenic cases. Emerg Infect Dis (In Press)
6. Hase T, Shishido S, Yamamoto S, Yamashita R, Nukima H, Taira S, Toyoda T, Abe K, Hamaguchi T, Ono K, Noguchi-Shinohara M, Yamada M, Kobayashi S. Rosmarinic acid suppresses Alzheimer’s disease development by reducing amyloid beta aggregation by increasing monoamine secretion. Sci Rep 9:8711, 2019
7. Hayashi K, Hamaguchi T, Sakai K, Nakamura K, Wakabayashi K, Shirasaki H, Yamada M. Neuronal intranuclear inclusion disease showing blepharoptosis and positive serum anti-acetylcholine receptor antibody without myasthenia gravis. J Neurol Sci 400:119-121, 2019
8. Kobayashi A, Matsuura Y, Takeuchi A, Yamada M, Miyoshi I, Mohri S, Kitamoto T. A domain responsible for spontaneous conversion of bank vole prion protein. Brain Pathol 29:155-163, 2019
9. Minikel EV, Vallabh SM, Orseth MC, Brandel JP, Haïk S, Laplanche JL, Inga Z, Parchi P, Capellari S, Safar J, Kenny J, Fong JC, Takada LT, Ponto C, Hermann P, Knipper T, Stehmann C, Kitamoto T, Ae R, Hamaguchi T, Sanjo N, Tsukamoto T, Mizusawa H, Collins SJ, Chiesa R, Roiter I, de Pedro-Cuesta J, Calero M, Geschwind MD, Yamada M, Nakamura Y, Mead S. Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology 93:e125-e134, 2019
10. Muramatsu D, Yamaguchi H, Iwasa K, Yamada M. Cerebellar hyperintensity lesions on diffusion-weighted MRI in MELAS. Intern Med 58:1797-1798, 2019
11. Muramatsu D, Yamaguchi H, Iwasa K, Yamada M. The author’s reply: Cerebellar stroke-like lesions? Intern Med 58:3207, 2019
12. Nakamura K, Hamaguchi T, Yamada M. Demyelinating polyneuropathy after long-term treatment with infliximab. Int J Rheum Dis 20:1781-1782, 2017 (2017年掲載漏れ)
13. Nakanishi M, Igarashi A, Ueda K, Brnabic AJM, Treuer T, Sato M,
Kahle-Wrobleski K, Meguro K, Yamada M, Mimura M, Arai H. Costs and Resource Use associated with community-dwelling patients with Alzheimer’s disease in Japan: Baseline results from the prospective observational GERAS-J Study. J Alzheimers Dis (In Press)
14. Nakanishi K, Jin Z, Homma S, Elkind MSV, Rundek T, Schwartz JE, Lee TC, Tugcu A, Yoshita M, DeCarli C, Wright CB, Sacco RL, Di Tullio MR. Night-time systolic blood pressure and subclinical cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study. Eur Heart J Cardiovasc Imaging 20:765-771, 2019
15. Noguchi-Shinohara M, Hirako K, Fujiu M, Sagae M, Samuta H, Nakamura H, Yamada M. Presence of a synergistic interaction between current cigarette smoking and diabetes mellitus on development of dementia in older adults. J Alzheimers Dis 71: 833-840, 2019
16. Oji Y, Hatano T, Ueno SI, Funayama M, Ishikawa K, Okuzumi A, Noda S, Sato S, Satake W, Toda T, Li YP, Hino-Takai T, Kakuta S, Tsunemi T,
Yoshino H, Nishioka K, Hattori T, Mizutani Y, Mutoh T, Yokochi F, Ichinose Y, Koh K, Shindo K, Takiyama Y, Hamaguchi T, Yamada M, Farrer MJ, Uchiyama Y, Akamatsu W, Wu YR, Matsuda J, Hattori N. Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease. Brain (In Press)
17. Sakai K, Ikeda T, Ishida C, Komai K, Yamada M. Delusions and visual hallucinations in a patient with Parkinson’s disease with dementia showing pronounced Lewy body pathology in the nucleus basalis of Meynert. Neuropathology 39:319-323, 2019
18. Sakai K, Ueda M, Fukushima W, Tamaoka A, Shoji M, Ando Y, Yamada M. Nationwide survey on cerebral amyloid angiopathy in Japan. Eur J Neurol 26:1487-1493, 2019
19. Sakai K, Ishida C, Motozaki Y, Tagami A, Komai K, Yamada M. Somatic sprouts of the Purkinje cells in a patient with multiple system atrophy. Neuropathology 38:407-410, 2018 (2018年掲載漏れ)
20. Shima A, Hamaguchi T, Tada Y, Yamada M. Treatment with Rituximab in the acute phase of relapsing remitting multiple sclerosis: a case report. Intern Med (In Press)
21. Tada Y, Hamaguchi T, Ikeda Y, Iwasa K, Nishida Y, Nakamura M, Sano A, Yamada M. Chorea-acanthocytosis with a novel mutation in the vacuolar protein sorting 13 homolog A gene: a case report. J Neurol Sci (In Press)
22. Takahashi K. Effect of dosage reduction on peripheral blood lymphocyte count in patients with multiple sclerosis receiving long-term fingolimod therapy. J Clin Neurosci 63:91-94, 2019
23. Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Silvestri NJ, Conwit R, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR, MGTX Study Group. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Lancet Neurol 18:259-268, 2019
24. Yoshida S, Tada H, Nishikawa T, Nakagawa-Kamiya T, Nakahashi T, Sakai K, Sakata K, Kawashiri M, Yamada M, Takamura M. Antegrade balloon aortic valvuloplasty for the highly frail patient with severe aortic stenosis and transthyretin-type cardiac amyloidosis. Intern Med (In Press)
Reviews
1. Takamori M. Synaptic compensatory mechanism and its impairment in autoimmune myasthenic diseases. J Immune Sci 3:6-13, 2019
2. Yamada M, Hamaguchi T, Sakai K. Acquried cerebral amyloid angiopathy: an emerging conept. Prog Mol Biol Transl Sci 168:85-95, 2019
3. Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, Yoshita M. Diagnostic criteria for dementia with Lewy bodies: Updates and future directions. J Mov Disord (In Press)
Presentations (International meeting)
Invited lectures
1. Shinohara M, Yamada M. Blood vitamin C levels are associated with reduction of Apolipoprotein E E4-related risks of cognitive decline in women: the Nakajima study. 19th Tokyo Metropolitan Institute of Medical Science International Symposium, Tokyo, February 8, 2019
2. Shinohara M, Komatsu J, Sakai K, Hamaguchi T, Yamada M. Dementia research in Kanazawa: From clinical and epidemiological studies to molecular pathogenesis and prevention. 2nd Japan-Germany Symposium on Advanced Preventive Medicine 2019, Kanazawa, October 3-4, 2019
3. Yamada M. 認知症と地域社会と生活〜認知症になる前の備え〜。第2回認知症国際アジア会議 in 加賀、加賀、January 11-12, 2019
4. Yoshikawa H, Adachi Y. Student Support Program by Psychologists and Neurologist. 2019 American College Health Association Annual Meeting. Denver, May 28‐ June 1, 2019
Presentations
1. Hamaguchi T, Sakai K, Kobayashi A, Kitamoto T, Ae R, Nakamura Y, Sanjo N, Arai K, Koide M, Katada F, Harada M, Murai H, Murayama S, Tsukamoto T, Mizusawa H, Yamada M. Characterization of “sporadic CJD” with history of neurosurgery to identify potentially iatrogenic cases. Asian Pacific Prion Symposium 2019(APPS2019), Wako, October 3-4, 2019
2.Harrison CH, Sakai K, Johnston DA, Holmes C, Boche D, Nicoll JAR. The role of capillary angiopathy and aquaporin 4 in ARIA Induced by Aβ Immunization. Alzheimer’s Association International Conference (AAIC2019), Los Angeles, July 14-18, 2019
3. Ishida C, Takahashi K, Motozaki Y, Shibata S, Asakawa M, Tagami A, Komai K. Availability of levodopa and clinicopathological features of patients with multiple system atrophy. International Congress of Parkinson’s Disease and Movement Disorders, Nice, September 22-26, 2019
4. Iwasa K, Yoshikawa H, Furukawa Y, Yamada M. Upregulation of programmed cell death ligand 1 expression in the skeletal muscle of patients with myasthenia gravis. 24th World Congress of Neurology, Dubai, October 27-31, 2019
5. Komai K, Ishida C, Takahashi K, Tagami A, Motozaki Y, Kawashima A. Pulmonary pathology of amyotrophic lateral sclerosis patients with non-invasive ventilation. 24th World Congress of Neurology, Dubai, October 27-31, 2019
6. Komai K, Ishida C, Takahashi K, Tagami A, Motozaki Y, Kawashima A. The cause of death in pathologically confirmed amyotrophic lateral sclerosis with invasive tracheostomy ventilation, a retrospective institute-based study. 24th World Congress of Neurology, Dubai, October 27-31, 2019
7. Komai K, Ishida C, Takahashi K, Tagami A, Motozaki Y, Kawashima A. The cause of death in pathologically confirmed amyotrophic lateral sclerosis with mechanical ventilation assist, a retrospective Institute-based study. 30th International Symposium on ALS/MND, Perth, December 4-7, 2019
8. Komatsu J, Samuraki M, Nakajima K, Arai H, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakamura H, Nakano S, Nakashima K,
Nishio Y, Orimo S, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K,
Wada K, Washimi Y, Yamashina S, Yamasaki J, Yoshita M, Yamada M. 123I-MIBG myocardial scintigraphy for the diagnosis of DLB : a multi-center three-year follow-up study. International Lewy Body Dementia Conference, Las Vegas, June 24-26, 2019
9. Matsubayashi T, Akaza M, Sanjo N, Hamaguchi T, Hayashi Y, Shimohata T, Yamada M, Yokota T. Focal sharp waves are specific in the early stage of MM2 cortical form of sCJD. Asian Pacific Prion Symposium 2019(APPS2019), Wako, October 3-4, 2019
10. Mizusawa H, Hamaguchi H, Yamada M. Iatrogenic Aβ transmission. 24th World Congress of Neurology, Dubai, October 27-31, 2019
11. Sato K, Nishizaki F, Yamashita K, Terashita K, Tsukahara N, Sakajiri K. Introduction of exercise class “PD Gym in KMC” for patients with Parkinson’s disease. 5th World Parkinson Congress, Kyoto, June 5, 2019
12. Shinohara M, Abe C, Yuki-Nozaki S, Dohmoto C, Mori A, Sakai K, Iwasa K, Yokoji H, Komai K, Yamada M. Higher blood vitamin C levels are associated with reduced risk of cognitive decline in apolipoprotein E E4-Positive women: The Nakajima Study. Alzheimer’s Association International Conference (AAIC2019), Los Angeles, July 14-18, 2019
13. Takahashi K, Motozaki Y, Ishida C, Komai K. The role of microglia in amyotrophic lateral sclerosis pathogenesis. XIV European Meeting on Glial Cells in Health and Disease, Porto, July 10-13, 2019
14. Wißfeld J, Nozaki I, Mathews M, Brault E, van Outryve d’Ydewalle C, Picardi P, Redaelli L, Tarroni P, Ebneth A, Pradier L, Brüstle O, Neumann H. Microglial Siglec-3/CD33. PHAGO 4th General Assembly meeting, London, October 28-30, 2019
15. Wißfeld J, Mathews-Arjendra M, Nozaki I, Raschka T, Ebeling C, Ebneth A, Brüstle O, Neumann H. Deletion of CD33 in human iPSC-derived microglia results in a proinflammatory microglia phenotype. Cluster Science Days 2019, Bonn, November 4-5, 2019
16. Yoshita M, Tsuji S, Yokoyama K, Sakamoto H. Efficacy and safety of composite supplement containing ferulic acid and Angelica archangelica extract in patients with MCI: A randomized, double blind, placebo controlled study. The 14th International Conference on Alzheimer’s & Parkinson’s Diseases, Lisbon, March 26-31, 2019
17. Yuki-Nozaki S, Shinohara M, Domoto C, Ikeda Y, Samuraki M, Iwasa K, Yokogawa M, Asai K, Komai K, Nakamura H, Yamada M. Differences in Dementia Beliefs and Intention to Attend a Future Dementia Screening between Public Screeners and in-Home Screeners: The Nakajima Study. Alzheimer’s Association International Conference (AAIC2019), Los Angeles, July 14-18, 2019
